Beta Bionics Q3 EPS $(0.52) Beats $(0.53) Estimate, Sales $35.505M Beat $34.722M Estimate

Beta Bionics (NASDAQ:BBNX) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0.53) by 1.89 percent. This is a 57.58 percent decrease over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $35.505 million which beat the analyst consensus estimate of $34.722 million by 2.26 percent. This is a 30.28 percent increase over sales of $27.253 million the same period last year.